Press release | Official website vaccine against COVID-19 Sputnik V.

Main
Newsroom
Press Releases

Press Releases

Argentina and Russia continue to successfully work together to accelerate the vaccination campaign and generate scientific evidence regarding the interchangeability of vaccines

Press release, 04.08.2021

Combination of the first component of Sputnik V vaccine (Sputnik Light vaccine) with vaccines by AstraZeneca, Sinopharm and Moderna demonstrates high safety profile during the study in Argentina’s Buenos-Aires province

Press release, 04.08.2021

SPUTNIK V TEAM STATEMENT ON PRODUCTION SCALE UP IN AUGUST AND SEPTEMBER

Press release, 04.08.2021

Laboratorios Richmond to provide Argentina with over 3 million doses of the second component of the Sputnik V vaccine in August with the first 150,000 doses to become available for vaccination this week

Press release, 03.08.2021

Test batch of the Sputnik V vaccine produced in Uzbekistan

Press release, 31.07.2021

The world’s first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik Light) in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination

Press release, 30.07.2021

Sputnik V approved for use in Chile

Press release, 21.07.2021

First batch of the Sputnik V vaccine produced in Vietnam

Press release, 21.07.2021

Sputnik V vaccine against coronavirus authorized in Nigeria

Press release, 15.07.2021

Single-dose Sputnik Light vaccine registered in Kazakhstan

Press release, 15.07.2021

1 2 3 4 5